Search

everythinglearnresearchcommunity

for

Search:↓

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Polycystic Ovary Syndrome (PCOS) is a common but often undiagnosed disorder in women that can cause irregular periods, infertility, and other symptoms, and can be managed with lifestyle changes, medication, and sometimes surgery.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The document concludes that more research is needed to fully understand the causes of PCOS.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Anti-aging treatments like hair transplants, minoxidil, and finasteride effectively promote hair growth.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

A specific genetic marker is linked to male pattern baldness in Han Chinese men.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

MitoQ may help treat hair loss by boosting hair growth pathways.

MC4R gene variants not linked to female hair loss.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Genomic approach finds new possible treatments for hair loss.

A specific RNA can help hair growth in baldness by boosting stem cell activity.

A genetic region near the PAX1 gene is linked to a higher risk of scoliosis in females.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

New genes linked to male pattern baldness were found on chromosome 20p11.